Anthem Biosciences (ANTHEM.NS) Earnings Analysis
Anthem Biosciences (ANTHEM.NS) has no confirmed upcoming earnings date. Last quarter (2026-07-21) it beat with EPS 3.4 INR vs 1.8 INR est (+88.9%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 75.83.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ANTHEM.NS next report earnings?
No confirmed upcoming earnings date is currently scheduled for ANTHEM.NS. This page updates as the calendar is published.
ANTHEM.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 3.4 INR | 1.8 INR | +88.9% | Beat |
| 2026-02-05 | 1.85 INR | 2.1 INR | -11.9% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
ANTHEM.NS valuation and analyst view
| Trailing P/E | 75.83 |
|---|---|
| Trailing EPS | 10.228 INR |
| Price / book | 14.39 |
| Dividend yield | 0.26% |
| Market cap | 437.52B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Anthem Biosciences (ANTHEM.NS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ANTHEM.NS. This page updates as the calendar is published.
Did ANTHEM.NS beat earnings last quarter?
In its 2026-07-21 report, ANTHEM.NS posted EPS of 3.4 INR versus a 1.8 INR estimate — a beat of 88.9%.
What is ANTHEM.NS's earnings track record?
Over the last 2 reported quarters with consensus data, ANTHEM.NS beat estimates 1 times (50%).
What is ANTHEM.NS's current P/E ratio and EPS?
ANTHEM.NS trades at a trailing P/E of 75.83 on trailing EPS of 10.228034790761281 INR.
What do analysts rate ANTHEM.NS?
ANTHEM.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.